Similar articles

• Impaired degradation of chondroitin sulfate in GM2-gangliosidosis.

  Yutaka T, Kato T, Okada S, Yabuuci H. Yutaka T, et al. Clin Genet. 1982 Oct;22(4):165-71. doi: 10.1111/j.1399-0004.1982.tb01430.x. Clin Genet. 1982. PMID: 6217929
• Diagnosis of Tay-Sachs disease by estimation of beta-N-acetylhexosaminidase activity using a radiolabeled hyaluronic acid-derived trisaccharide substrate.

  Yutaka T, Kato T, Midorikawa M, Doke M, Okada S, Yabuuchi H. Yutaka T, et al. Clin Chim Acta. 1984 Feb 28;137(2):159-68. doi: 10.1016/0009-8981(84)90176-1. Clin Chim Acta. 1984. PMID: 6231138
• Sequential degradation of a chondroitin sulphate trisaccharide by lysosomal enzymes from embryonic-chick epiphysial cartilage.

  Ingmar B, Wasteson A. Ingmar B, et al. Biochem J. 1979 Apr 1;179(1):7-13. doi: 10.1042/bj1790007. Biochem J. 1979. PMID: 475761 Free PMC article.
• The liver in lipid storage disease: biochemical basis of pathogenesis and clinical features.

  Brady RO, James SP, Barranger JA. Brady RO, et al. Prog Liver Dis. 1982;7:331-46. Prog Liver Dis. 1982. PMID: 6810410 Review. No abstract available.
• Tay-Sachs disease-causing mutations and neutral polymorphisms in the Hex A gene.

  Myerowitz R. Myerowitz R. Hum Mutat. 1997;9(3):195-208. doi: 10.1002/(SICI)1098-1004(1997)9:3<195::AID-HUMU1>3.0.CO;2-7. Hum Mutat. 1997. PMID: 9090523 Review.